Vitamin D Deficiency With Selected Vitamin D Receptor Gene Polymorphism in Gestational Hypertension

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

180 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-01

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aim to look into the prevalence of Vitamin D deficiency among Malaysian pregnant women and its associated risk factors. Subsequently, vitamin D deficient women with and without gestational hypertension will be investigated for their genetic variation to look for the association of VDR genetic variation and hypertensive disorders in pregnancy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Vitamin D and Preeclampsia

NCT01648842

Vitamin D Deficiency Defined as Serum 25OHD < 75 Nmol/l or 30ng/ml Preeclampsia Neonatal Hypercalcemia +1 more

COMPLETED

Vitamin D Status and Metabolism in Human Pregnancy

NCT03051867

Pregnancy

COMPLETED

Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women

NCT07288801

Pre-eclampsia Pregnancy Vitamin D

RECRUITING PHASE4

Impact of Maternal Body Weight on Vitamin D Status During Pregnancy

NCT02713009

Obesity Vitamin D Deficiency

COMPLETED NA

Pregnancy Outcome and Vitamin D Level Among Vitamin D Supplementation During Pregnancy

NCT04591847

Pregnancy Outcome Among Vitamin D Supplementation During Pregnancy

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypertensive disorders of pregnancy account for approximately 14% of maternal mortality globally and is the fourth leading cause of maternal mortality in Malaysia. Despite this, the mechanisms and pathogenesis are still unknown. Vitamin D deficiency (hypovitaminosis vitamin D) has been shown to be one of the causes of gestational hypertension(GH).

Several populations have observed the association of single nucleotide polymorphisms (SNPs) of vitamin D receptor (VDR) to vitamin D deficiency among pregnancy complications, including GH. Alarming cases of hypovitaminosis D in sunny areas including Malaysia, highly imply the need to understand the genetic factor. Hence, genotyping VDR variants among pregnant women is essential for early vitamin D supplementation strategy. To investigators knowledge, there has been no published study conducted among Malaysian population on the association of VDR genetic variation and GH. Therefore, this study aim to investigate the prevalence of vitamin D deficiency and its association of VDR SNPs to the development of GH among Malaysian pregnant mothers, with the main focus on Malays, representing the largest ethnic in Malaysia.

The prevalence will be determined through a cross-sectional study involving 363 pregnant women recruited in Hospital Pengajar UPM (HPUPM) and Hospital Serdang, Selangor. Relevant socio-demographic, clinical and anthropometric data will be collected using structured interviewer-administered questionnaire. Blood specimens for the analysis of vitamin D will be done. The association will be determined in a case-control study involving 180 pregnant women who fulfilled the criteria, recruited from phase 1 study. Their blood will be further analysed for the variants of the VDR gene \[(BsmI(rs1544410), FokI(rs2228570), TaqI(rs731236)\] to look for the association.

This study expected to provide more evidence for early personalised intervention of vitamin D supplementation due to anticipated individual genetic variability. This antenatal care programme will reduce the government expenditures, reduce maternal and fetal morbidity and mortality while strengthening Malaysia's healthcare system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertensive Disorder of Pregnancy Vitamin D Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1- normotensive women

Women with vitamin D deficiency and normotensive during pregnancy

Blood taking

Intervention Type DIAGNOSTIC_TEST

Blood test for vitamin D level and DNA extraction for VDR gene polymorphism

2- women with hypertensive disorder in pregnancy

Women with Vitamin D deficiency and hypertensive disorder in pregnancy

Blood taking

Intervention Type DIAGNOSTIC_TEST

Blood test for vitamin D level and DNA extraction for VDR gene polymorphism

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood taking

Blood test for vitamin D level and DNA extraction for VDR gene polymorphism

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Malay pregnant women with gestational age between 20 weeks till 42 weeks. (The gestational age will be determined from the first day of the last menstrual cycle or measurement of fetal crown rump length)
2. Malay pregnant women with viable pregnancy with or without pregnancy induced hypertension or its complications (pre-eclampsia, eclampsia, HELLP syndrome etc).
3. Literate in either English or Malay languages.
4. Agreement to follow-up till delivery and provision of written informed consent.

Exclusion Criteria

1. Non-viable pregnancy at the time of recruitment.
2. Women already on vitamin D supplements or any other drugs that can interfere with vitamin D absorption or metabolism at the time of recruitment.
3. Women with chronic hypertension diagnosed prior to pregnancy.
4. Pregnant women with any other chronic disease that is known to affect vitamin D such as, autoimmune disease and any malignancy

Minimum Eligible Age

19 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes